Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
Kestra Medical Technologies (Nasdaq: KMTS) will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 2:20 p.m. PT.
Rhea-AI Summary
Kestra Medical Technologies (Nasdaq: KMTS) will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 2:20 p.m. PT.
Investors and interested parties can watch a live webcast and access a replay via the Kestra investor relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – KMTS
On Apr 29, the day this news came out, KMTS closed 9.93% below the previous close.
Data tracked by StockTitan Argus for the Apr 29 session.
Key Figures
- Q3 FY2026 revenue
- $24.6M
- Quarter ended January 31, 2026; +63% year over year
- Gross margin
- 52.6%
- Q3 FY2026, up from 43.4% prior-year period
- FY2026 revenue guidance
- $93M
- Raised guidance; implies 55% growth vs fiscal 2025
- Cash and equivalents
- $291M
- As of January 31, 2026 per 10-Q and 8-K
- Q3 net loss
- $34.2M
- Quarter ended January 31, 2026; losses widened with expansion
- Equity offering size
- 6.9M shares; $149.3M net
- December 2025 equity offering proceeds noted in 10-Q
- ASSURE WCD patients
- Over 33,000 patients
- Cumulative use as of January 2026 in S-3ASR prospectus
- Last close pre-shelf
- $19.93
- Nasdaq closing price on March 31, 2026 disclosed in S-3ASR
Historical Context
-
Showcasing Cardiac Recovery System and ASSURE WCD at Heart Rhythm 2026.
-
Recognition as a 2026 USA TODAY Top Workplaces award winner.
-
Named finalist for 2026 GeekWire Deal of the Year for 2025 IPO.
-
Strong Q3 growth, higher gross margin, raised FY26 revenue guidance.
-
Announcement of Q3 FY2026 earnings release and conference call timing.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13 at 2:20 p.m. Pacific Time.
Interested parties may access the live webcast and a replay of the presentation by visiting the Kestra investor relations website.
About Kestra Medical Technologies
Kestra Medical Technologies is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact Neil Bhalodkar neil.bhalodkar@kestramedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.